These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10586361)

  • 21. Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma.
    Sandhu SS; Symes A; A'Hern R; Sohaib SA; Eisen T; Gore M; Christmas TJ
    BJU Int; 2005 Mar; 95(4):522-5. PubMed ID: 15705072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Survival analysis of interferon-alpha on locally advanced clear cell renal cell carcinoma after radical nephrectomy].
    Xia J; Li X; Chen XQ; Li X; Zeng H; Wei Q; Zhang P; Zhu YC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):91-4. PubMed ID: 22455140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.
    Uygur MC; Usubütün A; Ozen H; Ayhan A; Kendi S
    J Exp Clin Cancer Res; 1999 Sep; 18(3):397-401. PubMed ID: 10606187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Partial nephrectomy for renal cell carcinoma using a microwave tissue coagulator--postoperative recurrence and renal function].
    Fujimoto K; Tanaka N; Hirao Y
    Hinyokika Kiyo; 2005 Aug; 51(8):511-5. PubMed ID: 16164265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of bilateral synchronous renal cell carcinoma treated with partial nephrectomy with temporary occlusion of the segmental renal artery (segmental nephrectomy)].
    Naruke Y; Kanai S
    Hinyokika Kiyo; 1993 Jul; 39(7):653-6. PubMed ID: 8362686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Successful treatment for renal cell carcinoma with lung metastases by interleukin-2 and interferon-alfa: a case report].
    Sakata Y; Ogura Y; Wakita T; Hayashi N; Sugimura Y
    Hinyokika Kiyo; 2003 Jul; 49(7):389-91. PubMed ID: 12968479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bilateral radical nephrectomy and kidney transplantation as treatment for asynchronous bilateral renal cell carcinoma. A case report].
    Rodríguez-Covarrubias F; Gabilondo-Navarro F
    Gac Med Mex; 2006; 142(1):67-9. PubMed ID: 16548295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transperitoneal laparoscopic radical and partial nephrectomy in patients with cirrhosis: report of three cases.
    Hayn MH; Averch TD; Jackman SV
    Can J Urol; 2009 Aug; 16(4):4770-3. PubMed ID: 19671237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of postoperative interferon-alpha adjuvant therapy for non-metastatic renal cell carcinoma.
    Gotoh A; Shirakawa T; Hinata N; Wada Y; Hara I; Fujisawa M; Kawabata G; Okada H; Arakawa S; Kamidono S
    Int J Urol; 2004 May; 11(5):257-63. PubMed ID: 15147539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience with partial nephrectomy for renal cell carcinoma].
    Tanaka T; Yasumoto R; Masuda C; Nishisaka N; Kawano M
    Hinyokika Kiyo; 2001 Feb; 47(2):73-6. PubMed ID: 11280889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant autologous tumour cell-lysate vaccine versus no adjuvant treatment in patients with M0 renal cell carcinoma after radical nephrectomy: 3-year interim analysis of a German multicentre phase-III trial.
    Doehn Ch; Richter A; Lehmacher W; Jocham D
    Folia Biol (Praha); 2003; 49(2):69-73. PubMed ID: 12779015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Against: The case for cytoreductive nephrectomy for the management of metastatic renal cell carcinoma.
    Carver BS
    J Urol; 2009 Sep; 182(3):833-4. PubMed ID: 19616224
    [No Abstract]   [Full Text] [Related]  

  • 33. [Primary metastasized hypernephroma: therapy and follow-up].
    Hienert VG; Latal D; Kühböck J; Rummelhardt S
    Z Urol Nephrol; 1987 Dec; 80(12):669-74. PubMed ID: 3442132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Synchronous bilateral renal cell carcinoma].
    Hernández-Silverio González N; Bañares Baudet F; Gutiérrez Hernández P; Rodríguez P
    Actas Urol Esp; 1997 Mar; 21(3):260-3. PubMed ID: 9324892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II cytotoxic chemotherapy trials in renal cell carcinoma: 1983-1988.
    Yagoda A
    Prog Clin Biol Res; 1990; 350():227-41. PubMed ID: 2201045
    [No Abstract]   [Full Text] [Related]  

  • 37. Synchronous resections of intra-abdominal pathologies during radical nephrectomy. A case-linked cohort study evaluation of outcomes.
    Somani BK; Nicol G; Bhavan R; Swami S; Nabi G;
    Eur J Surg Oncol; 2009 Aug; 35(8):844-51. PubMed ID: 18976878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal cell carcinoma invading the inferior vena cava: use of a "temporary" vena cava filter to prevent tumor emboli during nephrectomy.
    Wellons E; Rosenthal D; Schoborg T; Shuler F; Levitt A
    Urology; 2004 Feb; 63(2):380-2. PubMed ID: 14972500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Two cases of hyperthyroidism induced by interferon-alpha therapy for renal cell carcinoma].
    Umemoto S; Izumi K; Kanno H
    Hinyokika Kiyo; 2007 Apr; 53(4):225-9. PubMed ID: 17515071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.